Clinical Trial Update: A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) [Phase 2]

View source ↗

Summary

Phase 2 safety study of liposomal cyclosporine A for bronchiolitis after hematopoietic cell transplantation was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome
• Graft-versus-host Disease
• Stem Cell Transplant Complications

Drugs mentioned

• Liposomal cyclosporine A (cyclosporine A liposome formulation)

Snippet

Sponsor: Zambon SpA | Conditions: Bronchiolitis Obliterans Syndrome (BOS), GVHD, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2023-10-03